image description

News. Other News

Juventas Therapeutics new therapeutic delivery approach trial initiated, featured in press

Juventas Therapeutics new therapeutic delivery approach trial initiated, featured in press
November 27, 2013

Cleveland Clinic-led group gets $10 million to become one of three NIH Centers for Accelerated Innovations

Cleveland Clinic-led group gets $10 million to become one of three NIH Centers for Accelerated Innovations
Angela Townsend, The Plain Dealer, September 26, 2013
Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, reports treating the first patient in its STOP-HF trial. The 90-patient, placebo-controlled, randomized double-blinded Phase II study is evaluating the safety and efficacy for JVS-100 in patients with late stage heart failure. Dr. Amit Patel, the Director of Clinical Regenerative Medicine at University of Utah Medical Center, treated the patient.

Juventas Therapeutics doses first patient in Phase II STOP-HF trial

Juventas Therapeutics
PRNewswire-USNewswire, August 20, 2012
Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, reports treating the first patient in its STOP-HF trial. The 90-patient, placebo-controlled, randomized double-blinded Phase II study is evaluating the safety and efficacy for JVS-100 in patients with late stage heart failure. Dr. Amit Patel, the Director of Clinical Regenerative Medicine at University of Utah Medical Center, treated the patient.

Cleveland Clinic Spin-Off Company, Cleveland Heart Inc., Receives $30 Million Investment for Development of Artificial Heart

Cleveland Heart Inc.
Innovation, July 16, 2012
Cleveland Clinic Spin-Off Company, Cleveland Heart Inc., Receives $30 Million Investment for Development of Artificial Heart

Juventas Therapeutics Raises $22.2 Million Series B Financing

Juventas Therapeutics
PRNewswire, July 16, 2012
Juventas Therapeutics, a clinical-stage regenerative medicine company, announced today that it has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures

Out of view of patients, docs, Clinic shop allows for tool rehab, new idea development

Cleveland Clinic Medical Device Solutions
Crain’s Cleveland Business, January 9, 2012
Surgeons and other doctors who perform miracles get most of the limelight at the Cleveland Clinic, but in the basement of its main campus, a crew of machinist, fabricators, engineers and researchers does impressive work, too –

Steris Corp. and Philips Healthcare deal add jobs, punch to Northeast Ohio’s biomedical economy

Philips Healthcare
cleveland.com, December 20, 2011
With Philips Healthcare and Steris Corp. expecting to add 200 local jobs within a year, state and local leaders see more proof that Northeast Ohio’s medical economy can compete on a national – and sometimes global – stage.